GlassScriptPhysician profile
Marco Swanson
NPI 1386148047
$4,086.27
in general payments reported to CMS, 2019-2025
10 companies · $857 in 2025
The $857 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2021: $49.80 · 2022: $1,389 · 2023: $192 · 2024: $1,467 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434 · Travel and Lodging: $900 · Long Term Medical Supply Or Device Loan: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.82 |
| Travel and Lodging | $899.87 |
| Long Term Medical Supply Or Device Loan | $181.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,233.96 | 2019-2022 | |
| Abbvie INC. | $741.48 | 2023-2025 | Botox |
| Mentor Worldwide LLC | $607.46 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Medical Device Business Services, INC. | $593.08 | 2024 | |
| Integra Lifesciences Corporation | $586.46 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Genzyme Corporation | $110.86 | 2025 | |
| Revance Therapeutics, INC. | $101.88 | 2025 | Daxxify |
| Dilon Technologies, INC. | $49.61 | 2023 | Hemoblast Bellows |
| Janssen Biotech, INC. | $36.00 | 2025 | Simponi, Tremfya, Stelara |
| Leo Pharma INC. | $25.48 | 2024 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.